BioStem Technologies (BioStem Technologies) Total Stockholders Equity : $-3.53 Mil (As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is BioStem Technologies Total Stockholders Equity?

BioStem Technologies's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $-3.53 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. BioStem Technologies's Book Value per Share for the quarter that ended in Sep. 2023 was $-0.26. The ratio of a company's debt over equity can be used to measure how leveraged this company is. BioStem Technologies's Debt-to-Equity for the quarter that ended in Sep. 2023 was -1.71.

BioStem Technologies Total Stockholders Equity Historical Data

The historical data trend for BioStem Technologies's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioStem Technologies Total Stockholders Equity Chart

BioStem Technologies Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

-1.61

-4.09

-5.80

-5.96

-4.08

BioStem Technologies Quarterly Data
	Sep15	Dec15	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Dec21	Mar22	Sep22	Dec22	Mar23	Sep23
Total Stockholders Equity	Get a 7-Day Free Trial															-	-	-4.08	-4.57	-3.53

BioStem Technologies (OTCPK:BSEM) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

BioStem Technologies's Book Value per Share for the quarter that ended in Sep. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-3.526	-	0)	/	13.5831
	=	-0.26

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

BioStem Technologies's Debt-to-Equity for the quarter that ended in Sep. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.613	+	1.41)	/	-3.526
	=	-1.71

BioStem Technologies Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of BioStem Technologies's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BioStem Technologies (BioStem Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioStem Technologies Inc (OTCPK:BSEM) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

2836 Center Port Circle, Pompano Beach, FL, USA, 33064

Website

https://www.biostemtechnologies.com

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its proprietary approach, Local MicroEnvironment Activation, uses combinations of Small Molecules, Cytokines, and Growth Factors to activate the microenvironment within the body to create communication for repair in the tissue. The Company offers a comprehensive portfolio of high-quality brands that are trademarked and include RHEO, AEON, OROPRO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC.